Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 898-903

  Lieberfarb, Marshal E ^a   Schultz, Delray ^b   Whittington, Richard ^c   Malkowicz, Bruce ^c   Tomaszewski, John E ^c   Weinstein, Michael ^d   Wein, Alan ^c   Richie, Jerome P ^d   D'Amico, Anthony V ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b University of Millersville   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Outcome; Prostate cancer; Prostate specific antigen; Radiation therapy; Radical prostatectomy

Indexed keywords

PATIENT TREATMENT; RADIATION; RADIOTHERAPY; TUMORS;

BIOPSIES;

ONCOLOGY;

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMISTRY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RISK; SCORING SYSTEM; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR BIOPSY;

BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; TIME FACTORS;

EID: 0037100123     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02812-2     Document Type: Article

References (15)

1. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
2. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
3. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
4. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer
5. An algorithm for predicting non-organ confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen levels
6. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy
7. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy
8. A multi-variable analysis evaluating the role of the percent positive biopsies and endorectal coil MRI in predicting extraprostatic disease and time to postoperative PSA failure in intermediate-risk prostate cancer patients
9. Natural history of progression after PSA elevation following radical prostatectomy
10. Histologic grading and staging of prostatic carcinoma
11. Free, complexed, and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios
12. Non-parametric estimation from incomplete observations
13. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database
14. Optimizing patient selection for prostate monotherapy